We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Barr, Kos Pharma In Talks To Settle Niaspan Patent Litigation

Law360 (March 30, 2005, 12:00 AM EST) -- Barr Pharmaceuticals Inc. and Kos Pharmaceuticals Inc. are in talks to settle their outstanding patent litigation regarding Kos' cholesterol reducing drug Niaspan, the two companies said Wednesday.

The case is currently...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.